SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Infinity Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?


To: tuck who wrote (134)11/19/2006 10:23:17 PM
From: Mike McFarland  Respond to of 210
 
Well, for the moment they seem to be staying out
of each other's way.

I hope I have this right:

Kosan: Velcade combo in refractory myeloma

Infinity: Monotherapy in GIST--redesigned with
no holiday period, new MTD needs to be established.

IPI-504 works best for KIT cancers, particular
mutuation does not matter, a good slide show for GIST patients:
liferaftgroup.org